To include your compound in the COVID-19 Resource Center, submit it here.

Cardiome begins Phase III arrhythmia trial

Cardiome (TSE:COM) began the Phase III ACT 1

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE